Roche tops cancer reputation rankings as AstraZeneca climbs back
AstraZeneca has impressed oncology patient groups, rising to second place on PatientView’s corporate reputation ranking on the back…
Are Biosimilars Becoming a Key Pillar of Amgen’s Growth Story?
Historically known for its innovative biologic medicines such as Enbrel, Prolia and Repatha, AmgenAMGN has also emerged as…
Switzerland population cap vote explained
A photo shows a poster depicting U.S. President Donald Trump, Russian President Vladimir Putin and Chinese President Xi…
President Trump’s Drug Pricing Policies Could Hurt Drugmakers’ Profits. Time to Sell Pharma Stocks?
President Trump has made it a priority to address the U.S.’s high drug prices. His administration’s Most-Favored-Nation (MFN)…
Roche’s Genentech Expands Investment in North Carolina Facility to $2B
Swiss pharma giant Roche’s RHHBY Genentech announced a significant expansion of its original investment in a new manufacturing…
Roche to invest $50 billion in US to avoid Trump tariffs, create 12,000 jobs
By John Revill ZURICH (Reuters) – Roche said on Tuesday it would invest $50 billion in the United…
Roche Commits $50B to U.S. Manufacturing, R&D as Tariffs Loom
With tariffs looming over biopharma, Roche became the latest industry giant to announce large-scale plans for new U.S.…